Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for MYGN

Stock NameMyriad Genetics Inc
TickerMYGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS62855J1043
LEI52990044IHUOUMETT163

Show aggregate MYGN holdings

News associated with MYGN

Myriad Genetics, Inc. (NASDAQ:MYGN) Receives $14.38 Consensus PT from Analysts
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been assigned a consensus rating of “Hold” from the sixteen brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the […] - 2025-08-07 03:12:46
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 86,973 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 43.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 285,229 shares of the company’s stock after purchasing an additional 86,973 shares […] - 2025-06-05 06:14:55
Squarepoint Ops LLC Acquires 29,524 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Squarepoint Ops LLC boosted its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 27.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 138,869 shares of the company’s stock after acquiring an additional 29,524 shares during the period. Squarepoint […] - 2025-05-30 05:34:51
ProShare Advisors LLC Has $370,000 Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)
ProShare Advisors LLC grew its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 12.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,982 shares of the company’s stock after purchasing an additional 2,933 shares during the period. ProShare Advisors LLC’s holdings […] - 2025-05-29 05:04:50
BNP Paribas Financial Markets Purchases 23,408 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
BNP Paribas Financial Markets boosted its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 51.1% in the fourth quarter, HoldingsChannel reports. The firm owned 69,183 shares of the company’s stock after buying an additional 23,408 shares during the quarter. BNP Paribas Financial Markets’ holdings in Myriad Genetics were worth $948,000 as of its […] - 2025-05-22 04:28:50
Myriad Genetics, Inc. (NASDAQ:MYGN) Stake Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 4.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 197,001 shares of the company’s stock after purchasing an additional 8,073 […] - 2025-05-21 05:40:50
Myriad Genetics, Inc. (NASDAQ:MYGN) Shares Sold by Comerica Bank
Comerica Bank trimmed its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 7.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 32,747 shares of the company’s stock after selling 2,525 shares during the period. Comerica Bank’s holdings in Myriad […] - 2025-05-16 05:20:57
Tudor Investment Corp ET AL Boosts Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)
Tudor Investment Corp ET AL boosted its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 212.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,935 shares of the company’s stock after acquiring an additional 33,937 shares […] - 2025-05-08 06:12:54
Hsbc Holdings PLC Buys 9,997 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Hsbc Holdings PLC grew its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 49.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,214 shares of the company’s stock after purchasing an additional 9,997 shares during the quarter. Hsbc Holdings […] - 2025-05-08 05:22:47
First Trust Advisors LP Sells 46,831 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
First Trust Advisors LP trimmed its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 25.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 139,545 shares of the company’s stock after selling 46,831 shares during the quarter. First Trust Advisors LP […] - 2025-05-06 05:41:06
Dimensional Fund Advisors LP Has $31.15 Million Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)
Dimensional Fund Advisors LP decreased its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The firm owned 2,272,355 shares of the company’s stock after selling 151,122 shares during the period. Dimensional Fund Advisors LP’s holdings in Myriad Genetics were worth $31,154,000 at the end of the […] - 2025-05-06 04:42:53
How The Pieces Add Up: IJR Headed For $129
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:51:52
Analysts Set Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target at $20.61
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned an average recommendation of “Hold” from the sixteen analysts that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. […] - 2025-04-29 02:50:53
Legal & General Group Plc Has $3.38 Million Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)
Legal & General Group Plc decreased its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 246,146 shares of the company’s stock after selling 5,363 shares during […] - 2025-04-23 05:58:48
Arrowstreet Capital Limited Partnership Sells 24,519 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Arrowstreet Capital Limited Partnership cut its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 13.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 153,062 shares of the company’s stock after selling 24,519 shares during the period. Arrowstreet […] - 2025-04-11 06:07:13
KLP Kapitalforvaltning AS Purchases New Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)
KLP Kapitalforvaltning AS acquired a new position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 18,000 shares of the company’s stock, valued at approximately $247,000. Several other institutional investors and hedge funds have also recently added […] - 2025-04-08 04:32:51
Corebridge Financial Inc. Sells 3,716 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Corebridge Financial Inc. decreased its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 7.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 47,667 shares of the company’s stock after selling 3,716 shares during the quarter. Corebridge Financial Inc.’s holdings in Myriad Genetics were worth $654,000 at the end of the most recent […] - 2025-04-07 04:32:49
Prudential Financial Inc. Sells 126,550 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Prudential Financial Inc. lessened its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 37.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 209,131 shares of the company’s stock after selling 126,550 shares during the period. Prudential […] - 2025-04-03 05:18:51
Myriad Genetics (NASDAQ:MYGN) Price Target Cut to $20.00 by Analysts at Scotiabank
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its target price lowered by Scotiabank from $24.00 to $20.00 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has a “sector outperform” rating on the stock. Scotiabank’s price objective indicates a potential upside of 127.27% from the company’s current price. Several other research […] - 2025-04-03 04:24:52
Myriad Genetics (NASDAQ:MYGN) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a hold rating to a buy rating in a report released on Tuesday morning. Several other research analysts have also commented on MYGN. Stephens reissued an “equal weight” rating and issued a $20.00 price objective on shares of Myriad Genetics in a research report […] - 2025-03-26 04:38:45
Natixis Advisors LLC Sells 110,685 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Natixis Advisors LLC reduced its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 34.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209,328 shares of the company’s stock after selling 110,685 shares during the quarter. Natixis Advisors LLC […] - 2025-03-24 05:54:59
Victory Capital Management Inc. Has $841,000 Stock Position in Myriad Genetics, Inc. (NASDAQ:MYGN)
Victory Capital Management Inc. lifted its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 6.4% during the 4th quarter, HoldingsChannel reports. The fund owned 61,341 shares of the company’s stock after buying an additional 3,711 shares during the period. Victory Capital Management Inc.’s holdings in Myriad Genetics were worth $841,000 as of its […] - 2025-03-21 07:10:48
AlphaQuest LLC Sells 5,360 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
AlphaQuest LLC lowered its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 67.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,641 shares of the company’s stock after selling 5,360 shares during the quarter. AlphaQuest LLC’s holdings in Myriad Genetics were worth $36,000 at the end of the most […] - 2025-03-21 06:08:54
Myriad Genetics (NASDAQ:MYGN) Downgraded by StockNews.com to “Hold”
StockNews.com cut shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a buy rating to a hold rating in a research note released on Thursday. A number of other equities research analysts also recently issued reports on the company. Morgan Stanley lowered their price objective on Myriad Genetics from $32.00 to $21.00 and set an […] - 2025-03-14 06:04:51
Nasdaq Climbs as Retaliatory Tariffs Spark Mixed Session on Wall Street
The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.43%. March E-mini S&P futures (ESH25 ) are up +0.79%, and March E-mini Nasdaq futures... - 2025-03-12 18:27:33
Myriad Genetics (NASDAQ:MYGN) Given New $11.50 Price Target at Piper Sandler
Myriad Genetics (NASDAQ:MYGN – Free Report) had its price objective cut by Piper Sandler from $14.00 to $11.50 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a neutral rating on the stock. Several other equities research analysts have also commented on MYGN. Leerink Partners lowered Myriad Genetics from an […] - 2025-03-05 06:45:04
Handelsbanken Fonder AB Acquires 3,500 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Handelsbanken Fonder AB boosted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 12.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 30,788 shares of the company’s stock after acquiring an additional 3,500 shares during the quarter. Handelsbanken Fonder AB’s holdings […] - 2025-03-03 06:59:05
Raymond James Reiterates Outperform Rating for Myriad Genetics (NASDAQ:MYGN)
Raymond James reaffirmed their outperform rating on shares of Myriad Genetics (NASDAQ:MYGN – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $19.00 price objective on the stock, down from their previous price objective of $27.00. Other research analysts have also recently issued reports about the company. Bank of […] - 2025-02-26 06:56:56
Myriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low Following Weak Earnings
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) hit a new 52-week low during trading on Tuesday following a dissappointing earnings announcement. The stock traded as low as $9.76 and last traded at $11.63, with a volume of 405660 shares changing hands. The stock had previously closed at $13.78. The company reported ($0.09) EPS for […] - 2025-02-26 04:20:57
New York State Teachers Retirement System Reduces Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)
New York State Teachers Retirement System trimmed its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 70,598 shares of the company’s stock after selling 3,302 shares during the […] - 2025-02-24 06:26:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc MYGN holdings

DateNumber of MYGN Shares HeldBase Market Value of MYGN SharesLocal Market Value of MYGN SharesChange in MYGN Shares HeldChange in MYGN Base ValueCurrent Price per MYGN Share HeldPrevious Price per MYGN Share Held
2025-09-26 (Friday)91,211USD 702,325USD 702,325
2025-09-25 (Thursday)91,211USD 707,797MYGN holding increased by 3648USD 707,7970USD 3,648 USD 7.76 USD 7.72
2025-09-24 (Wednesday)91,211USD 704,149USD 704,149
2025-09-17 (Wednesday)90,619USD 670,581MYGN holding decreased by -9062USD 670,5810USD -9,062 USD 7.4 USD 7.50001
2025-09-16 (Tuesday)90,619USD 679,643USD 679,643
2025-09-12 (Friday)90,027USD 651,795USD 651,795
2025-09-11 (Thursday)90,027MYGN holding increased by 1184USD 691,407MYGN holding increased by 77502USD 691,4071,184USD 77,502 USD 7.68 USD 6.91
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MYGN by Blackrock for IE00B3VWM098

Show aggregate share trades of MYGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY1,184 7.680* 9.86
2025-08-21SELL-238 5.830* 9.89 Profit of 2,353 on sale
2025-07-31BUY711 3.840* 9.95
2025-06-30SELL-474 5.310* 10.59 Profit of 5,019 on sale
2025-06-25SELL-238 5.120* 10.70 Profit of 2,547 on sale
2025-06-20SELL-476 4.920* 10.82 Profit of 5,152 on sale
2025-05-23BUY238 3.910* 11.83
2025-05-19SELL-238 4.430* 12.10 Profit of 2,879 on sale
2025-05-15SELL-714 4.110* 12.24 Profit of 8,737 on sale
2025-05-12SELL-238 4.250* 12.46 Profit of 2,965 on sale
2025-05-09SELL-238 3.890* 12.54 Profit of 2,983 on sale
2025-04-30SELL-238 7.410* 12.95 Profit of 3,081 on sale
2025-04-24SELL-476 7.370* 13.17 Profit of 6,270 on sale
2025-04-17SELL-238 7.640* 13.48 Profit of 3,207 on sale
2025-04-15SELL-714 8.010* 13.60 Profit of 9,707 on sale
2025-04-14SELL-714 8.080* 13.66 Profit of 9,750 on sale
2025-04-09SELL-952 8.450* 13.84 Profit of 13,179 on sale
2025-04-07SELL-1,666 8.070* 13.98 Profit of 23,294 on sale
2025-04-04SELL-2,380 8.130* 14.05 Profit of 33,441 on sale
2025-03-31BUY238 8.870* 14.24
2025-03-19SELL-476 9.930* 14.74 Profit of 7,017 on sale
2025-03-14SELL-1,428 10.070* 14.94 Profit of 21,337 on sale
2025-03-13SELL-478 9.700* 15.02 Profit of 7,178 on sale
2025-03-12SELL-8,126 10.410* 15.08 Profit of 122,567 on sale
2025-03-07SELL-478 10.180* 15.31 Profit of 7,320 on sale
2025-03-06SELL-717 10.520* 15.39 Profit of 11,033 on sale
2025-03-03SELL-239 10.390* 15.63 Profit of 3,736 on sale
2025-02-28BUY9,200 10.730* 15.71
2025-02-26SELL-212 11.560* 15.86 Profit of 3,362 on sale
2025-02-25SELL-636 11.740* 15.93 Profit of 10,132 on sale
2025-02-18BUY1,060 14.570* 16.07
2025-02-13BUY212 14.650* 16.16
2025-02-12BUY212 13.090* 16.22
2025-02-11BUY636 12.570* 16.29
2025-02-06BUY1,908 12.730* 16.55
2025-01-27BUY212 12.960* 17.37
2024-12-30BUY1,055 13.630* 17.88
2024-12-06BUY844 15.130* 18.16
2024-12-05BUY211 16.360* 18.22
2024-12-04BUY1,055 16.600* 18.28
2024-11-29BUY1,055 16.270* 18.51
2024-11-27BUY844 16.280* 18.70
2024-11-26BUY211 16.170* 18.81
2024-11-25BUY19,038 15.710* 18.96
2024-11-21BUY765 15.120* 19.35
2024-11-20BUY459 15.300* 19.57
2024-11-18BUY1,836 15.220* 20.13
2024-11-12BUY1,216 16.170* 20.39
2024-11-08BUY760 17.410* 20.61
2024-11-07BUY2,280 17.670* 20.83
2024-11-06BUY304 17.570* 21.10
2024-10-31BUY152 21.960* 22.23
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MYGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1998,7970263,14137.5%
2025-09-1887,7960406,68821.6%
2025-09-17144,0560336,24142.8%
2025-09-16159,5820394,91040.4%
2025-09-15173,5310356,20048.7%
2025-09-12273,0060766,55135.6%
2025-09-11264,8443855,09531.0%
2025-09-10115,5040320,17336.1%
2025-09-09117,8290834,12714.1%
2025-09-08293,5090568,19451.7%
2025-09-05142,1100429,58233.1%
2025-09-0490,0370255,78835.2%
2025-09-03187,8490373,12250.3%
2025-09-02417,098140736,94256.6%
2025-08-29210,7440471,70144.7%
2025-08-28218,7350367,38959.5%
2025-08-27141,0250200,61170.3%
2025-08-26124,1170205,57560.4%
2025-08-25130,42423225,71957.8%
2025-08-22167,0870332,61750.2%
2025-08-21227,6790355,89564.0%
2025-08-20274,77410542,34650.7%
2025-08-19182,97514441,62841.4%
2025-08-18197,8310527,42737.5%
2025-08-15209,8960350,46759.9%
2025-08-14326,2390825,82239.5%
2025-08-13283,8440647,80043.8%
2025-08-12241,6520445,08454.3%
2025-08-11333,2980591,64356.3%
2025-08-08353,2870848,90941.6%
2025-08-071,045,9832,1642,050,52451.0%
2025-08-063,016,8108,3557,314,58141.2%
2025-08-05346,937248635,53154.6%
2025-08-04156,2950344,86245.3%
2025-08-01183,7790522,49335.2%
2025-07-31353,60501,022,68134.6%
2025-07-30197,1690561,41435.1%
2025-07-29246,8101630,25439.2%
2025-07-28143,5020424,45733.8%
2025-07-25192,399207475,91140.4%
2025-07-24147,034100277,91752.9%
2025-07-23119,8030313,29038.2%
2025-07-22160,4822,781420,47338.2%
2025-07-21117,5930293,23940.1%
2025-07-18173,7980453,12138.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.